Willow Bio
PrivateSF-based biotech building AI-designed protein-degradation therapeutics for cancer indications.
Company
Founded
2023
Headquarters
San Francisco, United States
Financials
Total Funding
$51M
Funding History
2 rounds Series A Jul 15, 2026
$40M Seed Feb 15, 2024
$11M Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.